Post-procedure pain in preterm neonates undergoing retinopathy of prematurity (ROP) screening: a prospective cohort

Raman Singla1, Ankit Verma2, Vivek Kumar1

  • 1Division of Neonatology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.

Insights

Preterm infants experience significant pain immediately after retinopathy of prematurity (ROP) screening. Pain management strategies should be enhanced, considering pharmacological agents for ROP screening pain.

Area of Science:

  • Neonatal care
  • Ophthalmology
  • Pain management

Background:

  • Retinopathy of prematurity (ROP) screening is crucial for preterm infants.
  • Pain assessment during ROP screening is essential for appropriate care.

Purpose of the Study:

  • To evaluate pain intensity in preterm infants following retinopathy of prematurity (ROP) screening.
  • To assess pain levels up to 48 hours post-ROP screening using the Premature Infant Pain Profile-Revised (PIPP-R) score.

Main Methods:

  • Prospective cohort study conducted in a Level-III NICU in India.
  • 83 neonates undergoing their first ROP screening were assessed.
  • Pain was measured using the PIPP-R score at baseline and at 5 minutes, 30 minutes, 6, 24, and 48 hours post-procedure.

Main Results:

  • Pain scores significantly increased immediately after ROP screening (median PIPP-R: 10.5 at 5 min vs. 0 at baseline).
  • Moderate pain persisted for up to 6 hours post-procedure (median PIPP-R: 4.5).
  • 59% of neonates experienced severe pain (PIPP-R > 12) immediately after the screening.

Conclusions:

  • A majority of neonates experience severe pain immediately after ROP screening.
  • Mild to moderate pain continues for 6 hours post-ROP screening.
  • Additional pharmacological interventions should be considered to manage pain effectively after ROP screening.
Abstract

Related Concept Videos